Short answer · Medically reviewed summary · Last updated: 2026-05-08
Proximal 16p11.2 microdeletion syndrome does not have a unique, dedicated ICD-10 or ICD-9 code. Clinicians typically use the generic code Q93.59 (Other deletions of part of a chromosome) in ICD-10 or 758.39 (Other conditions involving autosomes) in ICD-9 to document the diagnosis for medical billing and records. Why is there no specific ICD code for Proximal 16p11.2 microdeletion syndrome? Rare genetic conditions, including Proximal 16p11.2 microdeletion syndrome, are often categorized under broader chromosomal abnormality codes because their specific manifestations are highly variable.
ICD10 code of Proximal 16p11.2 Microdeletion Syndrome and ICD9 code
ICD-10 and ICD-9 codes for Proximal 16p11.2 Microdeletion Syndrome, with classification details for clinicians, coders and patients.
Proximal 16p11.2 microdeletion syndrome does not have a unique, dedicated ICD-10 or ICD-9 code. Clinicians typically use the generic code Q93.59 (Other deletions of part of a chromosome) in ICD-10 or 758.39 (Other conditions involving autosomes) in ICD-9 to document the diagnosis for medical billing and records.
Why is there no specific ICD code for Proximal 16p11.2 microdeletion syndrome?
Rare genetic conditions, including Proximal 16p11.2 microdeletion syndrome, are often categorized under broader chromosomal abnormality codes because their specific manifestations are highly variable. The medical community uses these umbrella codes to ensure that individuals with Proximal 16p11.2 microdeletion syndrome can still access necessary insurance coverage and clinical services, even without a disease-specific billing code.
What are the clinical characteristics of Proximal 16p11.2 microdeletion syndrome?
This syndrome is caused by a recurrent deletion of approximately 600 kilobases on chromosome 16. Individuals with Proximal 16p11.2 microdeletion syndrome often present with a range of neurodevelopmental and physical traits, including:
- Developmental delay or intellectual disability (ranging from mild to moderate).
- Speech and language impairments.
- Increased risk for autism spectrum disorder (ASD).
- Macrocephaly (larger than average head size) in some patients.
- Increased susceptibility to obesity and metabolic challenges.
How is the diagnosis of Proximal 16p11.2 microdeletion syndrome confirmed?
The definitive diagnosis for Proximal 16p11.2 microdeletion syndrome is achieved through chromosomal microarray (CMA) testing. Because the deletion is too small to be detected by standard karyotyping, CMA is the gold standard for identifying these specific genetic variations. Our DiseaseMaps.org community currently includes 8 members living with Proximal 16p11.2 microdeletion syndrome who share their diagnostic journeys and management strategies.
Next steps
- Consult a clinical geneticist to review microarray results and discuss family testing.
- Connect with the DiseaseMaps.org community to share experiences with others navigating Proximal 16p11.2 microdeletion syndrome.
- Schedule multidisciplinary evaluations, including speech therapy, occupational therapy, and metabolic screening.
- Monitor for developmental milestones closely with a pediatric neurologist or developmental pediatrician.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider regarding a medical condition.
References
- NIH Genetic and Rare Diseases (GARD) Information Center: 16p11.2 deletion syndrome.
- Orphanet: 16p11.2 microdeletion syndrome (ORPHA:217276).
- OMIM (Online Mendelian Inheritance in Man): Chromosome 16p11.2 deletion syndrome (611913).
- Simons Searchlight: Research and clinical resources for 16p11.2 deletions.
